Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation

This publication has 17 references indexed in Scilit:

• Evidence That Silencing of the HPRT Promoter by DNA Methylation Is Mediated by Critical CpG Sites
  Published by Elsevier ,2001
• Methylation of specific CpG sites in the promoter region could significantly down-regulate p16INK4a expression in gastric adenocarcinoma
  International Journal of Cancer, 2000
• Absence of p53 gene mutations in hepatocarcinomas from a Mediterranean area of Spain
  Virchows Archiv, 1999
• Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
  Nature, 1998
• Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)
  Nucleic Acids Research, 1997
• Mutagenic and epigenetic effects of DNA methylation
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
• THE ROLE OF DNA METHYLATION IN CANCER GENETICS AND EPIGENETICS
  Annual Review of Genetics, 1996
• 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
  Nature Medicine, 1995
• Functional inactivation but not structural mutation of p53 causes liver cancer
  Nature Genetics, 1995
• Characterization of the human p53 gene promoter.
  Molecular and Cellular Biology, 1989